Related Experiment Video
Updated: Jul 18, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
[Acquired idiopathic thrombotic thrombocytopenic purpura: arguments for an autoimmune disease]
Paul Coppo1, Agnès Veyradier, Matthieu Monge
1Service d'Hématologie et de Thérapie Cellulaire, Hôpital Saint-Antoine, Paris. paulcoppo@aol.com
Abstract:
Thrombotic thrombocytopenic purpura (TTP) is a severe form of thrombotic microangiopathy (TMA) characterized by systemic platelet clumping, hemolytic anemia, and multiorgan failure. TTP results from a defect in ADAMTS13, a plasma enzyme specifically involved in the cleavage of highly hemostatic unusually large (UL) von Willebrand factor (vWF) multimers into smaller and less adhesive vWF forms. Failure to degrade these UL-vWF multimers leads to excessive platelet aggregation and capillary occlusion. ADAMTS13 deficiency is related to mutations of the encoding gene in hereditary TTP, whereas in acquired forms it results from autoantibodies that may alter the protein function. This latter finding strongly suggests that acquired idiopathic TTP corresponds to an autoimmune disease. Acquired idiopathic TTP appears to be associated with clinical features suggestive of autoimmunity in one third of cases. In two thirds, autoantibodies such as antinuclear antibodies may be observed. This review, based on an analysis of the literature and on French experience with TMA, focuses on the different autoimmune manifestations that may be observed in TTP, as well as the putative pathophysiological link between autoimmune manifestations and TTP.
Insights
Thrombotic thrombocytopenic purpura (TTP), a serious blood disorder, stems from issues with the ADAMTS13 enzyme. Acquired TTP often involves autoimmunity and autoantibodies, suggesting a link to autoimmune diseases.
Area of Science:
- Hematology
- Immunology
- Pathophysiology
Background:
- Thrombotic thrombocytopenic purpura (TTP) is a critical thrombotic microangiopathy (TMA) marked by platelet clumping, hemolytic anemia, and organ failure.
- TTP arises from deficient ADAMTS13 enzyme activity, crucial for cleaving large von Willebrand factor (vWF) multimers.
- Undegraded large vWF multimers cause excessive platelet aggregation and capillary occlusion, leading to TTP's severe manifestations.
Purpose of the Study:
- To explore the autoimmune manifestations associated with TTP.
- To investigate the potential pathophysiological connection between autoimmunity and TTP.
- To analyze literature and French TMA data regarding TTP and autoimmune links.
Main Methods:
- Literature review focusing on TTP and autoimmune phenomena.
- Analysis of clinical data from French TMA patients.
- Examination of autoantibodies, such as antinuclear antibodies, in TTP cases.
Main Results:
- Acquired idiopathic TTP is frequently linked to autoimmune conditions, observed in about one-third of cases.
- Autoantibodies, including antinuclear antibodies, are present in approximately two-thirds of acquired TTP patients.
- The study highlights a significant association between TTP and various autoimmune manifestations.
Conclusions:
- Acquired idiopathic TTP exhibits strong links to autoimmunity, suggesting it can be classified as an autoimmune disease.
- Autoantibodies play a critical role in the pathogenesis of acquired TTP.
- Understanding the interplay between autoimmunity and TTP is crucial for diagnosis and management.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Graves' Disease I: Introduction
Type I Diabetes I: Introduction
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Graves Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
